Xu‐zhao Li

1.1k total citations
48 papers, 847 citations indexed

About

Xu‐zhao Li is a scholar working on Molecular Biology, Complementary and alternative medicine and Pharmacology. According to data from OpenAlex, Xu‐zhao Li has authored 48 papers receiving a total of 847 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 15 papers in Complementary and alternative medicine and 8 papers in Pharmacology. Recurrent topics in Xu‐zhao Li's work include Natural product bioactivities and synthesis (9 papers), Bioactive natural compounds (6 papers) and Traditional Chinese Medicine Analysis (5 papers). Xu‐zhao Li is often cited by papers focused on Natural product bioactivities and synthesis (9 papers), Bioactive natural compounds (6 papers) and Traditional Chinese Medicine Analysis (5 papers). Xu‐zhao Li collaborates with scholars based in China, United States and Macao. Xu‐zhao Li's co-authors include Shuai‐nan Zhang, Fang Lü, Fang Lü, Shumin Liu, Shumin Liu, Zifeng Yang, Zhi‐Hong Jiang, Nanshan Zhong, Li‐Ping Bai and Wenbo Huang and has published in prestigious journals such as Journal of Ethnopharmacology, European Journal of Pharmacology and Clinica Chimica Acta.

In The Last Decade

Xu‐zhao Li

45 papers receiving 831 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xu‐zhao Li China 16 406 162 116 101 87 48 847
Snober S. Mir India 17 424 1.0× 119 0.7× 46 0.4× 120 1.2× 55 0.6× 61 978
Hiba Hasan Lebanon 6 328 0.8× 125 0.8× 89 0.8× 82 0.8× 33 0.4× 14 928
Vineet Mittal India 17 334 0.8× 114 0.7× 138 1.2× 131 1.3× 22 0.3× 70 1.1k
Bo Wei China 18 536 1.3× 169 1.0× 79 0.7× 61 0.6× 25 0.3× 58 1.1k
Ming‐Ling Yang Taiwan 18 413 1.0× 134 0.8× 165 1.4× 141 1.4× 24 0.3× 29 1.1k
Biyu Hou China 18 391 1.0× 98 0.6× 113 1.0× 142 1.4× 19 0.2× 32 974
Silvia Yumnam South Korea 19 609 1.5× 80 0.5× 92 0.8× 144 1.4× 24 0.3× 32 1.2k
Susanne Andres Germany 11 411 1.0× 69 0.4× 103 0.9× 99 1.0× 19 0.2× 17 1.3k

Countries citing papers authored by Xu‐zhao Li

Since Specialization
Citations

This map shows the geographic impact of Xu‐zhao Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xu‐zhao Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xu‐zhao Li more than expected).

Fields of papers citing papers by Xu‐zhao Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xu‐zhao Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xu‐zhao Li. The network helps show where Xu‐zhao Li may publish in the future.

Co-authorship network of co-authors of Xu‐zhao Li

This figure shows the co-authorship network connecting the top 25 collaborators of Xu‐zhao Li. A scholar is included among the top collaborators of Xu‐zhao Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xu‐zhao Li. Xu‐zhao Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shao, Qianqian, Shuai‐nan Zhang, & Xu‐zhao Li. (2025). Pathogenesis of osteoarthritis and treatment with traditional Chinese medicine: New perspectives on platelet aggregation. International Immunopharmacology. 167. 115665–115665.
2.
Yang, Bin, Qian Huang, Xu‐zhao Li, et al.. (2025). Fluoxetine in Functional Constipation with Somatic Symptom Disorder: Efficacy and Safety from a Propensity Score-Matched Cohort Study. Revista Española de Enfermedades Digestivas. 117(12). 737–744.
3.
Cao, Xin, Xu‐zhao Li, Lu Liu, et al.. (2024). Drug-repurposing by virtual and experimental screening of PFKFB3 inhibitors for pancreatic cancer therapy. European Journal of Pharmacology. 965. 176330–176330. 3 indexed citations
8.
Zhang, Shuai‐nan, et al.. (2023). Liver protein and metabolite biolabels reveal hepatoprotective effects and active compounds of Eucommiae folium: Exploration of new application of herb based on multi-omics and bioinformatics. Journal of Pharmaceutical and Biomedical Analysis. 239. 115870–115870. 4 indexed citations
9.
Li, Xu‐zhao, et al.. (2023). Disulfide Bond-Based SN38 Prodrug Nanoassemblies with High Drug Loading and Reduction-Triggered Drug Release for Pancreatic Cancer Therapy. International Journal of Nanomedicine. Volume 18. 1281–1298. 17 indexed citations
10.
Li, Xu‐zhao, et al.. (2020). Label-free quantitative proteomics positions the effects and mechanisms of Herba Lysimachiae on synovial diseases based on biolabel-led research pattern. Journal of Chromatography B. 1138. 121969–121969. 9 indexed citations
11.
Li, Xu‐zhao, et al.. (2018). Metabolomics analysis of oral mucosa reveals profile perturbation in reticular oral lichen planus. Clinica Chimica Acta. 487. 28–32. 10 indexed citations
12.
Zhang, Shuai‐nan, et al.. (2017). Analysis of human serum metabolome for potential biomarkers identification of erosive oral lichen planus. Clinica Chimica Acta. 468. 46–50. 11 indexed citations
13.
Li, Xu‐zhao, Yu Wang, Shuai‐nan Zhang, et al.. (2016). Urine metabolic profiling for the pathogenesis research of erosive oral lichen planus. Archives of Oral Biology. 73. 206–213. 12 indexed citations
14.
Zhang, Shuai‐nan, et al.. (2014). Neuroprotection or neurotoxicity? new insights into the effects of Acanthopanax senticosus harms on nervous system through cerebral metabolomics analysis. Journal of Ethnopharmacology. 156. 290–300. 29 indexed citations
16.
Yang, Zifeng, Li‐Ping Bai, Wenbo Huang, et al.. (2013). Comparison of in vitro antiviral activity of tea polyphenols against influenza A and B viruses and structure–activity relationship analysis. Fitoterapia. 93. 47–53. 135 indexed citations
17.
Li, Xu‐zhao, Shuai‐nan Zhang, Kexin Wang, et al.. (2013). Neuroprotective effects of extract of Acanthopanax senticosus harms on SH-SY5Y cells overexpressing wild-type or A53T mutant α-synuclein. Phytomedicine. 21(5). 704–711. 26 indexed citations
18.
Lü, Fang, et al.. (2013). Urinary metabonomics study on toxicity biomarker discovery in rats treated with Xanthii Fructus. Journal of Ethnopharmacology. 149(1). 311–320. 31 indexed citations
19.
Liu, Shumin, Na Wang, Pingping Chen, Xu‐zhao Li, & Changfeng Liu. (2013). Effect of Huanglianjiedu Tang on fever in rats induced by 2, 4-dinitrophenol. Journal of Traditional Chinese Medicine. 33(4). 492–499. 10 indexed citations
20.
Li, Xu‐zhao, Shuai‐nan Zhang, Shumin Liu, & Fang Lü. (2012). Recent advances in herbal medicines treating Parkinson's disease. Fitoterapia. 84. 273–285. 92 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026